Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 593 results for "a reddy"

Market Update: Dr Reddy#39;s, Hindalco fall over 2%; Bajaj Electricals zooms 10%, Infosys, RIL most active
Money Control

Market Update: Dr Reddy#39;s, Hindalco fall over 2%; Bajaj Ele...

The most active Nifty stocks were Infosys, Reliance Industries, Axis Bank, HDFC Standard Life and State Bank of India while the top losers were Adani Ports, Hindalco Industries, Dr Reddy#39;s Labs, Vedanta and Bajaj Auto. Money Control, 2 hours ago

342 images for a reddy

Business Standard, 1 day ago
Business Standard, 2 days ago
Mathrubhumi, 1 day ago
India Today, 3 days ago, 2 hours ago
DNA, 6 days ago
Money Control, 2 hours ago
Money Control, 2 hours ago
Money Control, 2 hours ago
Money Control, 1 day ago

Dr Reddys falls 2%, competition may rise for Vitorin that treats high cholesterol in blood

Dr Reddy#39;s had launched Vitorin generic in April 2017 in the US.
 Money Control2 hours ago Dr Reddy's launches Clofarabine injection in US market  Prokerala1 week ago Dr Reddy's in pink of health after launching drug  Business Standard1 month ago Dr Reddy's launches generic Sevelamer carbonate tablets in US  Business Standard1 month ago
Business Standard

Dr Reddy's requests USFDA for re-inspection of Duvvada facility in 2018

BS ReporterHyderabad, 21 November: Dr Reddy's Laboratories Limited on Wednesday informed the stock exchanges that the company has received the establishment inspection report(EIR) from the US Food and Drug Administration(USFDA) for its formulations ...
 Business Standard1 day ago Dr Reddy's spurts as company plans re-inspection  Business Standard2 days ago Dr Reddy's gets USFDA EIR for Vizag plant; inspection not concluded yet  Business Standard2 days ago Dr Reddy Laboratories receives EIR for facility at Duvvada, Vishakhapatnam  Business Standard2 days ago
Money Control

Dr Reddy#39;s Laboratories down 2%; Citi neutral on stock as near-term picture remains hazy

According to the firm, the company has one of the better US pipelines among the Indian companies, but the near-term picture remains hazy, given the pricing pressure in the US.
 Money Control1 day ago Dr Reddy's Lab recalls Famotidine tablets from US market  Business Standard1 month ago Dr Reddy#39;s Laboratories recalls Famotidine tablets from US market  Money Control1 month ago Dr Reddy's recalls over half a million Famotidine tablet bottles in US  Business Standard1 month ago
Money Control

India#39;s potential likely to materialise, says former RBI Governor YV Reddy

Moody#39;s ratings upgrade has interpreted that India#39;s potential is likely to materialise, that#39;s the word coming in from Former Reserve Bank of India (RBI) governor, YV Reddy. Speaking exclusively to Latha Venkatesh, Dr Reddy says the measures to ...
 Money Control2 days ago Cipla#39;s Dacogen approval to hit Dr Reddy#39;s: Credit Suisse  Money Control2 days ago

Ensure security to Deepika, family: K'taka HM writes to DGP

[India] Nov. 20 (ANI): Karnataka Home Minister Ramalinga Reddy wrote to DGP Karnataka on Monday to ensure the security of Bollywood actor Deepika Padukone and her family members. In the letter, Reddy even condemned Haryana's Bharatiya Janata Party (BJP) ...
 Sify2 days ago Will allow screening of Padmavati in K'taka if CBFC okays: Ramalinga Reddy  Deccan Herald1 week ago CBI has washed its hands off illegal mining scam: Ramalinga Reddy  Deccan Herald1 week ago CM candidate: Ramalinga Reddy stokes fire, bats for Siddaramaiah  Deccan Herald1 week ago
Money Control

Market Update: CNX Pharma outperforms led by Dr Reddy#39;s , Sun Pharma; RComm zooms over 11%

CNX Pharma zoomed over 2 percent and was distinctively the outperforming sector led by Dr Reddy#39;s Labs and Sun Pharma which jumped over 3 percent each while Cipla and Lupin were the other top pharma gainers.
 Money Control2 days ago Price-fixing allegations, a new worry to deal with for some leading Indian pharma companies in the US  Money Today2 weeks ago DRL, Sun, Glenmark among 18 under US lens on price fixing  Business Standard3 weeks ago Four pharma firms face US price-fixing charge  Business Standard3 weeks ago
Business Standard

No political differences with CPI(M) in Kerala: CPI gen secy

CPI general secretary S Sudhakar Reddy today downplayed the alleged differences with the CPI(M), and dubbed his party ministers' move to skip a cabinet meeting in Kerala recently as "differences inside the family".A war of words had erupted between the ...
 Business Standard2 days ago No political differences with CPM in Kerala: CPI gen secy  Mathrubhumi1 day ago Best package for Indian economy is to replace FM Jaitley: CPI  Business Standard1 month ago

Global cues, healthcare stocks propel equity indices

with strong buying in stocks of healthcare majors like Dr. Reddy's Lab, Sun Pharma, Cipla and Lupin, propelled the key Indian equity indices during the mid-afternoon trade session on Tuesday. According to market observers, the key indices discarded the ...
 Business Standard2 days ago

Closing Bell: Sensex, Nifty end on a flat note, midcaps outperform; Dr Reddy’s down 2%

Coal India, ONGC, GAIL and Tata Power were the top gainers, while ICICI Bank, DRL, and Ambuja Cements were the top losers.
 Money Control2 days ago Equities close marginally higher; Dr. Reddy's, ICICI Bank top BSE lags  Prokerala2 days ago Equities end higher on global cues, surge in metal stocks  Sify1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less